Abstract
Summary
Levothyroxine is used to treat low thyroid activity and to treat or suppress different types of goiters.
Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body's energy and metabolism. Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.
Levothyroxine treats hypothyroidism (low thyroid hormone). It is also used to treat or prevent goiter (enlarged thyroid gland), which can be caused by hormone imbalances, radiation treatment, surgery, or cancer.
The global Levothyroxine market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
In United States, the key Levothyroxine manufacturers are Abbott Ltd, Alara Pharm (Sandoz), Forest (Actavis), Merck Serono, Piramal Healthcare, Mylan, KING PHARMS R AND D, Jerome Stevens etc. Top 3 companies occupied about 69% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Levothyroxine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Levothyroxine.
The Levothyroxine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Levothyroxine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Levothyroxine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Abbott Ltd
Alara Pharm (Sandoz)
Forest (Actavis)
Merck Serono
Piramal Healthcare
Mylan
KING PHARMS R AND D
Jerome Stevens
Segment by Type
Slice in Solid
In Bottles for Injection
Segment by Application
Hospitals
Chemist's Shops
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Levothyroxine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Levothyroxine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Levothyroxine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body's energy and metabolism. Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.
Levothyroxine treats hypothyroidism (low thyroid hormone). It is also used to treat or prevent goiter (enlarged thyroid gland), which can be caused by hormone imbalances, radiation treatment, surgery, or cancer.
The global Levothyroxine market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
In United States, the key Levothyroxine manufacturers are Abbott Ltd, Alara Pharm (Sandoz), Forest (Actavis), Merck Serono, Piramal Healthcare, Mylan, KING PHARMS R AND D, Jerome Stevens etc. Top 3 companies occupied about 69% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Levothyroxine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Levothyroxine.
The Levothyroxine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Levothyroxine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Levothyroxine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Abbott Ltd
Alara Pharm (Sandoz)
Forest (Actavis)
Merck Serono
Piramal Healthcare
Mylan
KING PHARMS R AND D
Jerome Stevens
Segment by Type
Slice in Solid
In Bottles for Injection
Segment by Application
Hospitals
Chemist's Shops
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Levothyroxine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Levothyroxine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Levothyroxine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Table of Contents
1 Study Coverage
1.1 Levothyroxine Product Introduction
1.2 Market by Type
1.2.1 Global Levothyroxine Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Slice in Solid
1.2.3 In Bottles for Injection
1.3 Market by Application
1.3.1 Global Levothyroxine Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Hospitals
1.3.3 Chemist's Shops
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Levothyroxine Market Size Estimates and Forecasts
2.1.1 Global Levothyroxine Revenue 2019-2030
2.1.2 Global Levothyroxine Sales 2019-2030
2.2 Levothyroxine Market Size by Region: 2023 Versus 2030
2.3 Levothyroxine Sales by Region (2019-2030)
2.3.1 Global Levothyroxine Sales by Region: 2019-2024
2.3.2 Global Levothyroxine Sales Forecast by Region (2025-2030)
2.3.3 Global Levothyroxine Sales Market Share by Region (2019-2030)
2.4 Levothyroxine Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Levothyroxine Revenue by Region: 2019-2024
2.4.2 Global Levothyroxine Revenue Forecast by Region (2025-2030)
2.4.3 Global Levothyroxine Revenue Market Share by Region (2019-2030)
3 Global Levothyroxine by Manufacturers
3.1 Global Top Levothyroxine Manufacturers by Sales
3.1.1 Global Levothyroxine Sales by Manufacturer (2019-2024)
3.1.2 Global Levothyroxine Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Levothyroxine Manufacturers by Revenue
3.2.1 Global Levothyroxine Revenue by Manufacturer (2019-2024)
3.2.2 Global Levothyroxine Revenue Share by Manufacturer (2019-2024)
3.3 Global Levothyroxine Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Levothyroxine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Levothyroxine Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Levothyroxine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Levothyroxine Manufacturing Base Distribution, Product Type
3.5.1 Levothyroxine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Levothyroxine Product Type
3.5.3 Date of International Manufacturers Enter into Levothyroxine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Abbott Ltd
4.1.1 Abbott Ltd Company Information
4.1.2 Abbott Ltd Description, Business Overview
4.1.3 Abbott Ltd Levothyroxine Products Offered
4.1.4 Abbott Ltd Levothyroxine Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Abbott Ltd Levothyroxine Sales by Product in 2023
4.1.6 Abbott Ltd Levothyroxine Sales by Application in 2023
4.1.7 Abbott Ltd Levothyroxine Sales by Geographic Area in 2023
4.1.8 Abbott Ltd Recent Developments
4.2 Alara Pharm (Sandoz)
4.2.1 Alara Pharm (Sandoz) Company Information
4.2.2 Alara Pharm (Sandoz) Description, Business Overview
4.2.3 Alara Pharm (Sandoz) Levothyroxine Products Offered
4.2.4 Alara Pharm (Sandoz) Levothyroxine Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Alara Pharm (Sandoz) Levothyroxine Sales by Product in 2023
4.2.6 Alara Pharm (Sandoz) Levothyroxine Sales by Application in 2023
4.2.7 Alara Pharm (Sandoz) Levothyroxine Sales by Geographic Area in 2023
4.2.8 Alara Pharm (Sandoz) Recent Developments
4.3 Forest (Actavis)
4.3.1 Forest (Actavis) Company Information
4.3.2 Forest (Actavis) Description, Business Overview
4.3.3 Forest (Actavis) Levothyroxine Products Offered
4.3.4 Forest (Actavis) Levothyroxine Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Forest (Actavis) Levothyroxine Sales by Product in 2023
4.3.6 Forest (Actavis) Levothyroxine Sales by Application in 2023
4.3.7 Forest (Actavis) Levothyroxine Sales by Geographic Area in 2023
4.3.8 Forest (Actavis) Recent Developments
4.4 Merck Serono
4.4.1 Merck Serono Company Information
4.4.2 Merck Serono Description, Business Overview
4.4.3 Merck Serono Levothyroxine Products Offered
4.4.4 Merck Serono Levothyroxine Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Merck Serono Levothyroxine Sales by Product in 2023
4.4.6 Merck Serono Levothyroxine Sales by Application in 2023
4.4.7 Merck Serono Levothyroxine Sales by Geographic Area in 2023
4.4.8 Merck Serono Recent Developments
4.5 Piramal Healthcare
4.5.1 Piramal Healthcare Company Information
4.5.2 Piramal Healthcare Description, Business Overview
4.5.3 Piramal Healthcare Levothyroxine Products Offered
4.5.4 Piramal Healthcare Levothyroxine Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Piramal Healthcare Levothyroxine Sales by Product in 2023
4.5.6 Piramal Healthcare Levothyroxine Sales by Application in 2023
4.5.7 Piramal Healthcare Levothyroxine Sales by Geographic Area in 2023
4.5.8 Piramal Healthcare Recent Developments
4.6 Mylan
4.6.1 Mylan Company Information
4.6.2 Mylan Description, Business Overview
4.6.3 Mylan Levothyroxine Products Offered
4.6.4 Mylan Levothyroxine Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Mylan Levothyroxine Sales by Product in 2023
4.6.6 Mylan Levothyroxine Sales by Application in 2023
4.6.7 Mylan Levothyroxine Sales by Geographic Area in 2023
4.6.8 Mylan Recent Development
4.7 KING PHARMS R AND D
4.7.1 KING PHARMS R AND D Company Information
4.7.2 KING PHARMS R AND D Description, Business Overview
4.7.3 KING PHARMS R AND D Levothyroxine Products Offered
4.7.4 KING PHARMS R AND D Levothyroxine Sales, Revenue and Gross Margin (2019-2024)
4.7.5 KING PHARMS R AND D Levothyroxine Sales by Product in 2023
4.7.6 KING PHARMS R AND D Levothyroxine Sales by Application in 2023
4.7.7 KING PHARMS R AND D Levothyroxine Sales by Geographic Area in 2023
4.7.8 KING PHARMS R AND D Recent Development
4.8 Jerome Stevens
4.8.1 Jerome Stevens Company Information
4.8.2 Jerome Stevens Description, Business Overview
4.8.3 Jerome Stevens Levothyroxine Products Offered
4.8.4 Jerome Stevens Levothyroxine Sales, Revenue and Gross Margin (2019-2024)
4.8.5 Jerome Stevens Levothyroxine Sales by Product in 2023
4.8.6 Jerome Stevens Levothyroxine Sales by Application in 2023
4.8.7 Jerome Stevens Levothyroxine Sales by Geographic Area in 2023
4.8.8 Jerome Stevens Recent Development
5 Breakdown Data by Type
5.1 Global Levothyroxine Sales by Type (2019-2030)
5.1.1 Global Levothyroxine Sales by Type (2019-2024)
5.1.2 Global Levothyroxine Sales Forecast by Type (2025-2030)
5.1.3 Global Levothyroxine Sales Market Share by Type (2019-2030)
5.2 Global Levothyroxine Revenue Forecast by Type (2019-2030)
5.2.1 Global Levothyroxine Revenue by Type (2019-2024)
5.2.2 Global Levothyroxine Revenue Forecast by Type (2025-2030)
5.2.3 Global Levothyroxine Revenue Market Share by Type (2019-2030)
5.3 Levothyroxine Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Levothyroxine Sales by Application (2019-2030)
6.1.1 Global Levothyroxine Sales by Application (2019-2024)
6.1.2 Global Levothyroxine Sales Forecast by Application (2025-2030)
6.1.3 Global Levothyroxine Sales Market Share by Application (2019-2030)
6.2 Global Levothyroxine Revenue Forecast by Application (2019-2030)
6.2.1 Global Levothyroxine Revenue by Application (2019-2024)
6.2.2 Global Levothyroxine Revenue Forecast by Application (2025-2030)
6.2.3 Global Levothyroxine Revenue Market Share by Application (2019-2030)
6.3 Levothyroxine Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Levothyroxine Market Size YoY Growth 2019-2030
7.2 North America Levothyroxine Market Facts & Figures by Country
7.2.1 North America Levothyroxine Sales by Country (2019-2030)
7.2.2 North America Levothyroxine Revenue by Country (2019-2030)
7.3 North America Levothyroxine Sales by Type (2019-2024)
7.4 North America Levothyroxine Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Levothyroxine Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Levothyroxine Market Facts & Figures by Region
8.2.1 Asia-Pacific Levothyroxine Sales by Region (2019-2030)
8.2.2 Asia-Pacific Levothyroxine Revenue by Region (2019-2030)
8.3 Asia-Pacific Levothyroxine Sales by Type (2019-2024)
8.4 Asia-Pacific Levothyroxine Sales by Application (2019-2024)
9 Europe
9.1 Europe Levothyroxine Market Size YoY Growth 2019-2030
9.2 Europe Levothyroxine Market Facts & Figures by Country
9.2.1 Europe Levothyroxine Sales by Country (2019-2030)
9.2.2 Europe Levothyroxine Revenue by Country (2019-2030)
9.3 Europe Levothyroxine Sales by Type (2019-2024)
9.4 Europe Levothyroxine Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Levothyroxine Market Size YoY Growth 2019-2030
10.2 Latin America Levothyroxine Market Facts & Figures by Country
10.2.1 Latin America Levothyroxine Sales by Country (2019-2030)
10.2.2 Latin America Levothyroxine Revenue by Country (2019-2030)
10.3 Latin America Levothyroxine Sales by Type (2019-2024)
10.4 Latin America Levothyroxine Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Levothyroxine Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Levothyroxine Market Facts & Figures by Country
11.2.1 Middle East and Africa Levothyroxine Sales by Country (2019-2030)
11.2.2 Middle East and Africa Levothyroxine Revenue by Country (2019-2030)
11.3 Middle East and Africa Levothyroxine Sales by Type (2019-2024)
11.4 Middle East and Africa Levothyroxine Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Levothyroxine Supply Chain Analysis
12.2 Levothyroxine Key Raw Materials and Upstream Suppliers
12.3 Levothyroxine Clients Analysis
12.4 Levothyroxine Sales Channel and Sales Model Analysis
12.4.1 Levothyroxine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Levothyroxine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Levothyroxine Distributors
13 Market Dynamics
13.1 Levothyroxine Industry Trends
13.2 Levothyroxine Market Drivers
13.3 Levothyroxine Market Challenges
13.4 Levothyroxine Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer